PT - JOURNAL ARTICLE AU - Zeng, Wen AU - Feng, Xin AU - Huang, Jie AU - Du, Chuan AU - Qu, Dongming AU - Zhang, Xiang AU - Zhang, Jianquan TI - A Multi-center Study of COVID-19 with Multivariate Prognostic Analysis AID - 10.1101/2020.09.26.20202234 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.26.20202234 4099 - http://medrxiv.org/content/early/2020/09/28/2020.09.26.20202234.short 4100 - http://medrxiv.org/content/early/2020/09/28/2020.09.26.20202234.full AB - Purpose Coronavirus disease (COVID-19) pandemic is now a global health concern. However, there is no detailed analysis of the factors related to patients’ improvement.Patients and methods We compared the clinical characteristics, laboratory findings, CT images, and treatment of COVID-19 patients from two different cities in China. One hundred and sixty-nine patients were recruited from January 27 to March 17, 2020 at five hospitals in Hubei and Guangxi. They were divided into four groups according to age and into two groups according to presence of comorbidities. Multivariate statistical analyses were performed for the prognosis of the disease.Results Fifty-two patients (30.8%) had comorbidities, and the percentage of critical COVID-19was higher in the comorbidities group (11.6%vs.0.9%, p<0.05). Older patients had higher proportion of severe or critical disease. The results showed that lymphocyte count was significantly associated with the number of days from positive COVID-19 nucleic acid test to negative test; number of days from onset of symptoms to confirmation of diagnosis was significantly associated with the time it took for symptoms to improve; and number of days from onset of symptoms to confirmation of diagnosis and disease severity were significantly associated with chest computed tomography improvement.Conclusions Age, comorbidities, lymphocyte count, and SpO2 may predict the risk of severity of COVID-19. Early isolation, early diagnosis, and early initiation of management can slow down the progression and spread of COVID-19.Key Points Age and comorbidities can predict the risk of severity of COVID-19, Lymphocyte count and SpO2 may predict the risk of severity of COVID-19. Early isolation, Early diagnosis can slow down the progression of COVID-19Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no external funding.We would like to thank the three radiologists,Drs. YanyanShen, PengPeng, Dong Deng,who helped with the analysis and interpretation of the imaging data.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee associated with the Faculty of Medicine at The First Affiliated Hospital of Guangxi Medical University[2020(KY-E-06).]. Informed consent was done appropriately for subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in the manuscript is available